- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT00416988
Educational Program in Skin Self-Examination To Detect Melanoma in Healthy Participants
Skin Self-Examination for Early Detection of Melanoma: Intervention and Consequence
RATIONALE: An educational program may be effective in increasing monthly skin self-examinations to detect melanoma in healthy participants.
PURPOSE: This randomized clinical trial is studying how well an educational program works in increasing monthly skin self-examinations to detect melanoma in healthy participants.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
OBJECTIVES:
- Determine the incidence of monthly thorough skin self-examinations (TSE) for early detection of melanoma in healthy participants who are under routine care by their primary care physician.
- Determine the impact of the intervention package and the resulting change in TSE performance, in terms of visits to healthcare providers for skin problems, in these participants.
- Evaluate the efficacy of this intervention package in improving performance of TSE in these participants.
- Estimate potential effect of this intervention on health care resource use.
OUTLINE: This is a controlled, randomized study.
Two weeks prior to their appointment with their physician, participants undergo a baseline assessment. During the appointment, participants are randomized to 1 of 2 intervention arms.
- Arm I (control): Participants receive written educational materials and watch a video on healthy dietary habits during their appointment. They receive nutrition tip sheets, including information related to reducing fat, saturated fat, and cholesterol in the diet, at 2 and 6 months after their initial appointment. Participants also undergo telephone assessments at 2, 6, and 12 months after their initial appointment.
- Arm II (skin self-examinations): Participants undergo a 10- to 15-minute face-to-face counseling session with the study intervention specialist and receive training in thorough skin self-examination (TSE) directly after their appointment. They also receive written educational materials and watch a 25-minute video designed to motivate and teach them to do TSE. Two weeks later, participants receive a follow-up call from the same study intervention specialist. Participants receive tailored feedback at 2 and 6 months and a motivational postcard at 4 months after their initial appointment. Participants also undergo telephone assessments as in arm I.
Participating physicians seeing participants in both arms attend a 60-minute educational session regarding skin cancer detection, prevention, identification, and triage, supplemented by written materials. They are also trained and prompted to deliver a 30-second message emphasizing the desirability of performing monthly TSE during their appointment with participants.
After completion of the study intervention, participants are offered the educational materials of the intervention arm to which they were not randomized.
PROJECTED ACCRUAL: A total of 1,135 participants will be accrued for this study.
Studietype
Inschrijving (Verwacht)
Fase
- Niet toepasbaar
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
DISEASE CHARACTERISTICS:
Healthy participants who are scheduled for a routine or health maintenance visit with a participating primary care office that meets all of the following criteria:
- At least 50% of patients are being seen for regular ongoing general medical care
- Specializes in internal medicine (subspecialties allowed), family medicine, or obstetrics/gynecology
Employs at least 2 physicians who meet all of the following requirements:
- Agree to participate
- Work full-time, defined as at least 8 sessions per week of 3 or more hours
- Completed post-graduate training
- Not a federal employee or full-time hospital-based faculty
- Have been in practice at least 1 year
- Not planning on relocating or retiring within the next 3 years
PATIENT CHARACTERISTICS:
- Must be able to read in either English or Spanish
- Has no household member who has been previously enrolled on this study, including a person who has the same telephone number or address
- Not in acute discomfort
- Able to comply with intervention
- No impairment that would preclude skin self-examination
- Must be able to view video
- No illness or disability that would preclude participation in the study interview
PRIOR CONCURRENT THERAPY:
- Must not have been previously enrolled on this study
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Preventie
- Toewijzing: Gerandomiseerd
Medewerkers en onderzoekers
Sponsor
Medewerkers
Onderzoekers
- Studie stoel: Martin A. Weinstock, MD, PhD, Rhode Island Hospital
Publicaties en nuttige links
Studie record data
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Schatting)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- CDR0000454855
- RIH-R01-CA78800
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Melanoom (Huid)
-
Utah State UniversityActief, niet wervendOntvelling (skin-picking) stoornisVerenigde Staten
-
Ritamaria Di LorenzoVoltooidSKIN ADAPTOGEN EN SEBUM BALANCE EFFICIËNTIEItalië
-
Northwestern UniversityUniversity of Wisconsin, StoutVoltooidPerceptie van Skin of Color Clinics bij Afro-AmerikanenVerenigde Staten
-
Karolinska InstitutetRegion StockholmVoltooidTrichotillomanie | Ontvelling (skin-picking) stoornisZweden
-
National Taiwan University HospitalOnbekend
-
The Netherlands Cancer InstituteOnbekendStadium IV huidmelanoom | Oog; MelanomaNederland
-
University of AarhusDanish Cancer Society; AmbuFlexVoltooidMelanoma | Kwaliteit van het levenDenemarken
-
Herlev HospitalVoltooidMelanoma | HuidkankerDenemarken
-
Herlev HospitalVoltooidGeïntegreerde basiswetenschap binnen het instructieontwerp van patroonherkenningstraining (AISC-ISF)Melanoma | HuidkankerDenemarken
-
University Medical Center GroningenWervingMelanoma | Hoofd- en nekneoplasmata | MSI-H-kankerNederland
Klinische onderzoeken op educatieve interventie
-
Université de MontréalOnbekendChirurgische opleiding | Geavanceerde hechtvaardigheden
-
The University of Texas Health Science Center,...National Center for Advancing Translational Sciences (NCATS)Actief, niet wervend
-
Henry Ford Health SystemBlue Cross Blue Shield of Michigan FoundationVoltooidDiabetes mellitus, type 2Verenigde Staten
-
Idaho State UniversityNog niet aan het wervenGegamificeerde digitale interventie om de effectiviteit van exposure-therapie voor OCS te verbeterenExperimentele videogames | Gedragsbeoordeling
-
Vanderbilt UniversityAanmelden op uitnodigingMoeilijkheden bij het leren van wiskundeVerenigde Staten
-
National and Kapodistrian University of AthensUniversity of Thessaly; Aghia Sophia Children's Hospital of Athens; National Hellenic... en andere medewerkersVoltooidDiabetes mellitus type 2 | Telomeer verkortingGriekenland
-
Hackensack Meridian HealthAmerican Music Therapy AssociationWervingSchizofreniespectrum en andere psychotische stoornissen | Bipolaire stoornis | Angststoornis | Geestelijke gezondheidsproblemen | DepressiefVerenigde Staten
-
Evgenia E. PsarrakiVoltooidErnstige depressieve stoornisGriekenland
-
University of SurreySurrey and Borders Partnership NHS Foundation TrustWervingAanhoudende depressieve stoornisVerenigd Koninkrijk
-
Washington University School of MedicineSt. Jude Children's Research HospitalVoltooidKanker bij kinderen | Kinderkanker | Cardiale toxiciteitVerenigde Staten